E
0.24
+0.97%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$148.9m
FY2017FY2026
Net income
$44.9m
FY2017FY2026
Free cash flow
$22.8m
FY2017FY2026
Shareholders' equity
$98.9m
FY2017FY2026
Income statement
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $148.9m | $84.0m | $56.6m | $32.3m | $25.4m | $18.0m | $7.6m | $7.5m | $9.6m |
| Research and development | $5.7m | $8.0m | $6.9m | $4.1m | $5.1m | $5.5m | $7.6m | $9.6m | $8.3m |
| Operating income | $50.0m | $21.2m | $1.0m | $5.1m | $2.1m | −$2.3m | −$9.1m | −$9.1m | −$7.3m |
| Net income | $44.9m | −$4.3m | $20.1m | $8.9m | $5.1m | −$2.2m | −$9.3m | −$3.7m | $3.8m |
| Diluted earnings per share | 0.04 | -0.00 | 0.02 | 0.01 | 0.01 | -0.00 | -0.01 | -0.00 | 0.00 |
Balance sheet
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | $138.3m | $96.4m | $83.7m | $35.1m | $26.2m | $25.0m | $24.4m | $30.9m | $34.3m |
| Cash and short-term investments | — | — | — | $8.5m | $3.2m | $1.1m | $2.3m | $7.2m | $10.6m |
| Total liabilities | $39.4m | $42.9m | $26.1m | $9.9m | $10.0m | $14.3m | $13.0m | $12.4m | $8.6m |
| Debt | $2.8m | $8.9m | $9.4m | $1.7m | $2.2m | $3.7m | $4.0m | $4.0m | $2.6m |
| Shareholders' equity | $98.9m | $53.5m | $57.6m | $25.2m | $16.2m | $10.7m | $11.4m | $18.5m | $25.7m |
| Shares outstanding | 1,077m | 1,068m | 1,068m | 1,014m | 1,011m | 1,009m | 829m | 819m | 795m |
Cash flow
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | $23.7m | $7.5m | −$3.2m | $6.5m | $3.2m | −$1.8m | −$6.8m | −$4.8m | −$7.9m |
| Capital spending | −$925,626 | −$2.5m | −$809,653 | −$498,566 | −$329,981 | −$34,953 | −$19,130 | −$274,847 | −$1.1m |
| Free cash flow | $22.8m | $4.9m | −$4.0m | $6.0m | $2.9m | −$1.8m | −$6.8m | −$5.1m | −$9.0m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $32.4m | $40.7m | $31.6m | $36.3m | $40.2m | $32.0m | $14.4m | $18.9m |
| Operating income | $7.5m | $11.0m | $9.0m | $8.2m | $21.7m | $12.8m | $1.1m | $3.5m |
| Net income | $5.9m | $18.5m | $18.6m | $13.7m | −$5.9m | $17.0m | −$10.9m | −$11.0m |
| Diluted earnings per share | 0.01 | 0.02 | 0.02 | 0.01 | -0.01 | 0.02 | -0.01 | -0.01 |
| Cash from operations | $10.0m | $9.0m | −$5.0m | $5.0m | $14.0m | $3.0m | −$1.0m | $1.0m |
| Total assets | $139.7m | $138.3m | $126.4m | $117.2m | $111.3m | $96.4m | $90.8m | $88.2m |
| Debt | $2.8m | $2.8m | $2.8m | $2.8m | $3.0m | $3.0m | $3.1m | $3.1m |
| Shareholders' equity | $104.8m | $98.9m | $80.3m | $61.6m | $47.7m | $53.5m | $36.4m | $47.3m |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | -83.7% | 42.4% | 28.1% |
| Operating income | -70.9% | 88.4% | — |
| Net income | -78.3% | 54.6% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | 30.6% | 6.1% | 6.1% | 6.0% |
| Net margin | 17.4% | 13.0% | 13.0% | 12.9% |
Valuation history
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 5.8 | -121.3 | 28.7 | 0.0 | 3.4 | 6.0 | -22.5 | -8.0 | -9.8 | 11.7 |
| Price to sales | 1.7 | 6.2 | 10.2 | — | 0.9 | 1.2 | 2.8 | 9.9 | 4.8 | 4.6 |
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Return | -11% | 293% | 367% | 0% | -40% | -44% | 80% | -11% | 11% | -67% |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.